PatientsVille.com Logo

Urinary and Fluidasa

PatientsVille

Urinary Symptoms and Causes

Urinary incontinence (UI) is loss of bladder control. Symptoms can range from mild leaking to uncontrollable wetting. It can happen to anyone, but it becomes more common with age. Women experience UI twice as often as men.

Most bladder control problems happen when muscles are too weak or too active. If the muscles that keep your bladder closed are weak, you may have accidents when you sneeze, laugh or lift a heavy object. This is stress incontinence. If bladder muscles become too active, you may feel a strong urge to go to the bathroom when you have little urine in your bladder. This is urge incontinence or overactive bladder. There are other causes of incontinence, such as prostate problems and nerve damage.

Treatment depends on the type of problem you have and what best fits your lifestyle. It may include simple exercises, medicines, special devices or procedures prescribed by your doctor, or surgery.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Check out the latest treatments for urinary

urinary treatment research studies

Fluidasa clinical trials, surveys and public health registries


Find Drug Side Effect reports



Fluidasa Side Effects

Tremor (6)
Delirium (2)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Can claritine cause urinary problems?

Hi few days ago i went to my gp with urine burning pain leftside of belly bit blood in urine and now i have small swelling to my belly near belly button it feels sore and hurts when i touch it can anyone out there plz help me

Hi, I have had A UTI for feels like month now I was put on Cipro did not work now I am on Baxtrum, almost done with it but I am not getting better I feel worse now with aching in my left side. Whta is going on, I just feel not myself either. should I

I really hate utis how about you?

Iam starting antibiodic iam taking cerazett the pill i had sex 5 days ago can i get pregnant

My 2 yr old has just been prescribed this and has to take 5ml 2 times a day he has the suspension at 50mg. this was given for an infection found in water sample. reading the side effect list im worried. has anyone else had this for a child ?

48 years of age. I was diagnosed with urinary tract infection. Had one dose of monuril 3 gr. After 7 hours developed skin rash on the back, arms and neck, generally swelling of the face, specially below the eyes, Had oral antihistamine and went to

'Foreign proteins that gain access to the body through cuts and scrapes, through the digestive or circulatory systems, or through the urinary and reproductive systems are called ____.' Answer a) immunoglobulins

42 y.o. female, no medical hx. of urinary incontinence until the use of Mucinex D 1200mg po bid. Resolved after med. being discontinued.

58 year old female patient was prescribed cipro xr 500 twice a day for urinary tract infection. on 4th day, patient developed ithcy rashes. on 6thday, patient experienced low backpain and abdominal pain that felt like arthritic pain.&nb

After being diagnosed with urinary tract infection, had one dose of monuril 3 gr. 7 hours later developed skin rash in all upper body and severe swelling of the face, particularly round the eyes. I had 2 pills of celesemine. In the morning symtoms ha

After taking vistaril 25mh capsules i suffered from urinary retention. So bad I had to be hospitalized. I previously have been treated for an enlarged prostate.

Been on Flomaxtra for 2 months with the following affects. Urinary flow improved immediately but ejaculations ceased totally. Known as retro ejaculation. Penis became inflammed around the head and under the foreskin, Posthitis? but goes away when tab

Blurred vision, joint pain torn miniscus both knees, hot flashes, feeling cold, urinary tract infections seven in one year, some othr mild infections, GI problems, multiple

Can claritine cause urinary problems?

Could not urinate or have bowl movement for two days. By massaging my abdomin I was able to urinate(half hour). Developed urinary tract infection. Lost 20 pounds in two weeks.Have never been suicidal in my life. After taking cymba

Urinary Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients
Condition: Urinary Tract Infection
Interventions: Device: Silver Alloy-Coated Urinary Catheters;   Device: Conventional Urinary Catheter
Outcome Measures: Incidence of catheter associated Urinary tract infection;   Asymptomatic Urinary tract infection;   Bacteremic Urinary tract infection
2 Recruiting Urinary Urinary Nerve Growth Factor (NGF) as a Biomarker for Mixed Urinary Incontinence
Condition: Mixed Urinary Incontinence
Intervention: Procedure: Midurethral slings (MUS)
Outcome Measures: Difference in the baseline Urinary NGF level between patients with and without urgency incontinence at 6 months after midurethral slings;   Baselinec cut-off value of Urinary NGF level which can predict the patients whose urgency incontinence will be cured and whose urgency incontinence will not be cured.;   Difference in Urinary NGF level between pure SUI and MUI patients;   Changes in OAB symptoms (including urgency incontinence) and SUI after midurethral slings;   Correlation between changes in Urinary NGF and OAB symptoms (including urgency incontinence) after midurethral slings
3 Unknown  A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence
Conditions: Stress Urinary Incontinence;   Urgency Urinary Incontinence
Intervention: Drug: solifenacin
Outcome Measures: Changes in the number of urge Urinary incontinence episodes per 24 hours between baseline and week 12;   Percent change in the mean number of urge Urinary incontinence episodes per 24 hours;   Change in the mean number of urge Urinary incontinence episodes per 24 hours;   Change in the mean frequency of urination per 24 hours;   Percent change in the mean frequency of urination;   Changes in the mean and sum rating on the Bladder Sensation Scale per 24 hours;   Change in the mean number of severe urgency episodes per 24 hours;   Changes in overactive bladder symptom score (OABSS) questionnaire;   Changes in short urogenital distress inventory (UDI-6);   Changes in short incontinence impact questionnaire (IIQ-7);   Safety assessed by the incidence and severity of side effects
4 Not yet recruiting When to Perform Bladder Catheterization in Fast-track Hip and Knee Arthroplasty
Condition: Postoperative Urinary Retention (POUR)
Interventions: Procedure: increased interventional threshold for Urinary bladder catheterization (800 ml);   Procedure: Current used interventional threshold for Urinary bladder catheterization (500 ml);   Device: Intermittent bladder catheter
Outcome Measures: Number of patients receiving postoperative Urinary bladder catheterization;   Incidence of Urinary tract infections;   Number of voiding difficulties acquired postoperatively;   Number of readmissions due to urological issues (including urosepsis)
5 Recruiting Correlations of 3D Urethral and Paraurethral Sonographic Findings With Urodynamic Studies, Lower Urinary Tract Symptoms & Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms.
Conditions: Lower Urinary Tract Dysfunction;   Overactive Bladder Syndrome
Intervention:
Outcome Measures: Urethral/pelvic blood flow perfusion pattern between subgroups of women with lower Urinary tracts;   Urethral/pelvic blood flow perfusion pattern after antimuscarinics
6 Unknown  Day Zero Urinary Catheter Removal in Gen Thoracic Surgery Patients
Conditions: Postoperative Retention of Urine;   Postoperative Urinary Tract Infection
Intervention:
Outcome Measure: Evaluate rates of recatheterization due to Urinary retention and occurrence of Urinary tract infections in a general thoracic surgery population receiving thoracic epidural analgesia.
7 Recruiting Proteomic Pattern in Female Stress Urinary Incontinence: a Pilot Study
Condition: Female Stress Urinary Incontinence
Intervention: Other: collection of urine and blood sample
Outcome Measure: mass spectrometric measuring of Urinary proteomic secretome in diseased and healthy subjects (sequence coverage and number of identified proteins)
8 Recruiting Suprapubic Aspiration Versus Urinary Catheterization In Neonates.
Condition: Neonatal Urinary Tract Infection
Interventions: Procedure: Suprapubic Aspiration;   Procedure: Urinary Catheterization
Outcome Measures: Number of contaminated urine samples per SPA and UC;   Success rates of obtaining urine by SPA versus UC;   Time to perform the respective procedures;   Complication rates of SPA versus UC;   Contamination rates of SPA versus UC (excluding clean catch urine);   Number of attempts per procedure
9 Recruiting Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Condition: Stress Urinary Incontinence
Interventions: Biological: Roll-in;   Other: Placebo;   Biological: AMDC for USR
Outcome Measures: Number of leaks due to stress incontinence episodes, as recorded in a diary;   Stress leak frequency and pad weight composite endpoint
10 Not yet recruiting An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: botulinum toxin Type A
Outcome Measures: Percentage of Patients Who have Greatly Improved or Improved on the 4-Point Treatment Benefit Scale (TBS);   Change From Baseline in Number of Urinary Incontinence Episodes;   Time to Re-Injection of BOTOX®;   Number of Nocturia Episodes;   Usage of Incontinence Support Products;   Percentage of Patients Who Have at Least a 50% Reduction in Urinary Incontinence and Urinary Urgency Incontinence
11 Recruiting Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine
Condition: Recurrent Urinary Tract Infection
Interventions: Drug: LVX-AMX;   Drug: TCM
Outcome Measures: Recovery of recurrent Urinary tract infection;   Urinary albumin;   WBC conversion;   Urination frequency;   Recurrence;   urgency
12 Unknown  Compare the Therapeutic Effect Treated With Tamsulosin and Progesterone After ESWL( Extra Corporeal Shock Wave Lithotripsy) in Urinary Calculus
Condition: Urinary Calculus
Intervention: Drug: progesterone,tamsulosin,propantheline Bromide and nifedipine
Outcome Measure: different effect of these drugs use to treat Urinary calculus after ESWL
13 Recruiting Surgical vs. Medical Treatment of Urge Urinary Incontinence in Women
Condition: Urge Urinary Incontinence
Interventions: Drug: solifenacin;   Procedure: cesa/vasa
Outcome Measure: cure from urge Urinary symptoms
14 Not yet recruiting Transobturator Subtrigonal Tape vs Transobturator Suburethral Tape for Stress Urinary Incontinence
Condition: Stress Urinary Incontinence
Interventions: Procedure: transobturator subtrigonal tape S-TOT;   Procedure: Transobturator suburethral tape (TOT)
Outcome Measures: Stress Urinary incontinence resolution, without postoperative obstruction;   Complications
15 Not yet recruiting Intravesical Instillation of Hyaluronic Acid to Decrease Incidence of Urinary Tract Infection
Condition: Urinary Tract Infection
Intervention: Drug: Hyaluronic Acid
Outcome Measures: positive Urinary culture;   Urinary tract infection
16 Recruiting Study of Electroencephalogram (EEG) Measurement During Different Stimulations of the Lower Urinary Tract
Conditions: Healthy;   Nonneurogenic Neurogenic Bladder Dysfunction;   Neurogenic Bladder Dysfunction Nos
Intervention: Other: Electroencephalography
Outcome Measure: Establishment of somatosensory evoked potentials of lower Urinary tract stimulations
17 Not yet recruiting The Effectiveness of a Bladder Training Video for Management of Lower Urinary Tract Symptoms.
Conditions: Nonneurogenic Lower Urinary Tract Dysfunction;   Dysfunctional Elimination Syndrome
Intervention: Other: Educational Intervention
Outcome Measures: Improvement of Nonneurogenic Lower Urinary Tract Dysfunction symptoms;   Assess the Quality of Life of children with Nonneurogenic Lower Urinary Tract Dysfunction/Dysfunctional Elimination Syndrome.
18 Recruiting Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Biological: Urinary excretion of FLC immunoglobulin
Outcome Measures: change in Urinary protein/creatinine ratio;   changes in Urinary excretion of FLC;   methods for estimating the Urinary concentration of FLC
19 Recruiting Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy
Condition: Urinary Incontinence, Urge
Interventions: Drug: Anticholinergic medications;   Behavioral: Hypnotherapy
Outcome Measures: Urgency Urinary Incontinence episodes recorded on voiding diaries;   Evoked brain activation and resting connectivity on functional MRI;   Urinary urge incontinence cure;   Questionnaire scores;   Urinary frequency and pad counts;   Irritable bowel syndrome and bowel symptoms and/or Painful Bladder/Interstitial Cystitis in this population
20 Recruiting Urinary NGF as A Biomarker for Acute Bacterial Cystitis
Condition: Urinary Tract Infection
Interventions: Drug: Baktar 800mg h.s.;   Drug: Celecoxib 200mg QD
Outcome Measures: Change from Baseline in Urinary nerve growth factor (NGF) at different time points;   Change from Baseline in one-day voiding diary at different time points;   Change from Baseline in Overactive Bladder Symptom Score (OABSS) at different time points;   Change from Baseline in visual analog scale of pain (VAS) at different time points